Mayer Brown represents GW Pharmaceuticals plc on $101.1 million Nasdaq Global Market offering
Mayer Brown represented the London-based GW Pharmaceuticals plc, a biopharmaceutical company, in a $101.1 million US public offering and listing of American Depositary Shares on the Nasdaq Global Market in an offering led by Morgan Stanley & Co. LLC and Cowen and Company, LLC. The transaction follows GW Pharmaceuticals’ US initial public offering in May 2013, on which Mayer Brown also represented the company.